Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC Nilutamide | 63612-50-0 | 99.7% | 317.22 | 200 MG
SDP

Catalog No. 5000348705
Encompass_Preferred

Nilutamide is an orally active nonsteroidal androgen receptor antagonist. It has affinity for androgen receptors but not for progestogen, estrogen, or glucocorticoid receptors. It can be used for research on prostate cancer and also exhibits antischistosomal properties. It inhibits hexobarbital hydroxylase, benzphetamine N-demethylase, benzo(a)pyrene hydroxylase, and 7-ethoxycoumarin O-deethylase activities in human liver microsomes.

  • Orally active nonsteroidal androgen receptor antagonist
  • Used for research on prostate cancer
  • Exhibits antischistosomal properties
  • Inhibits hexobarbital hydroxylase and other enzyme activities

Catalog No. 50-003-48705 Supplier Medchemexpress LLC Supplier No. HY13702200MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Nilutamide is an orally active nonsteroidal androgen receptor antagonist. It has affinity for androgen receptors but not for progestogen, estrogen, or glucocorticoid receptors. It can be used for research on prostate cancer and also exhibits antischistosomal properties. It inhibits hexobarbital hydroxylase, benzphetamine N-demethylase, benzo(a)pyrene hydroxylase, and 7-ethoxycoumarin O-deethylase activities in human liver microsomes.

  • Orally active nonsteroidal androgen receptor antagonist
  • Used for research on prostate cancer
  • Exhibits antischistosomal properties
  • Inhibits hexobarbital hydroxylase and other enzyme activities

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.